Seoul, South Korea

Chul Yong Park


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Chul Yong Park

Introduction

Chul Yong Park, based in Seoul, South Korea, is a prominent inventor known for his groundbreaking work in the field of gene therapy, particularly concerning hemophilia. With a total of three patents to his name, he has made significant strides in developing methods to correct genetic mutations that lead to this life-altering condition.

Latest Patents

Among his most notable inventions is a method involving RNA guided endonuclease aimed at targeting the blood coagulation factor VIII intron 1 inversion gene. This innovative approach provides a systematic method for inducing an inversion in the normal F8 gene and corrects any existing inversions in hemophilia A patients. The invention effectively reproduces the inversions responsible for severe hemophilia A, making it a crucial tool for studying the disease's development mechanisms and for researching potential therapeutic agents. Furthermore, the inversion-corrected induced pluripotent stem cells developed through this methodology present a promising pathway for restoring a genotype to a wild type-like state, enabling effective treatment options for hemophilia A without the need for traditional gene or protein delivery.

Career Highlights

Chul Yong Park is affiliated with the Industry-Academic Cooperation Foundation at Yonsei University. His work in this capacity allows him to merge academic research with practical applications, enhancing the potential for innovative therapies based on his patent developments.

Collaborations

Throughout his career, Park has collaborated with esteemed colleagues, including Dong Wook Kim and Jin Soo Kim. These partnerships have been instrumental in driving forward the research and technologies that stem from his innovative patents.

Conclusion

Chul Yong Park's contributions to the field of hemophilia research exemplify the power of innovation and collaboration in medicine. His patents not only address critical genetic issues but also provide a foundation for future therapeutic advancements in treating this condition. As he continues his work, the potential for further breakthroughs remains promising, underscoring the importance of dedicated inventors in the pursuit of health and well-being.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…